Liangqian Jiang

498 total citations
11 papers, 362 citations indexed

About

Liangqian Jiang is a scholar working on Molecular Biology, Oncology and Biomedical Engineering. According to data from OpenAlex, Liangqian Jiang has authored 11 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Biomedical Engineering. Recurrent topics in Liangqian Jiang's work include Nanoplatforms for cancer theranostics (3 papers), Peptidase Inhibition and Analysis (2 papers) and Phytochemistry and Bioactivity Studies (2 papers). Liangqian Jiang is often cited by papers focused on Nanoplatforms for cancer theranostics (3 papers), Peptidase Inhibition and Analysis (2 papers) and Phytochemistry and Bioactivity Studies (2 papers). Liangqian Jiang collaborates with scholars based in China and United States. Liangqian Jiang's co-authors include Huihui Liu, Bing Li, Guoxiang Liu, Yujuan Wang, Yajing Huang, Feng Zhu, Feng Zhu, Guoxiang Liu, Yujuan Wang and Shuhua Zheng and has published in prestigious journals such as Journal of Cell Science, International Journal of Biological Macromolecules and Frontiers in Pharmacology.

In The Last Decade

Liangqian Jiang

8 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liangqian Jiang China 8 175 147 53 48 38 11 362
Xuegan Yang China 8 191 1.1× 152 1.0× 57 1.1× 46 1.0× 16 0.4× 9 399
Xuejun Fu China 11 159 0.9× 113 0.8× 29 0.5× 63 1.3× 14 0.4× 31 405
Sivanesan Dhandayuthapani United States 10 179 1.0× 58 0.4× 24 0.5× 21 0.4× 17 0.4× 20 309
Quan Luo China 13 354 2.0× 122 0.8× 23 0.4× 9 0.2× 45 1.2× 24 546
Yong Bae Seo South Korea 14 178 1.0× 37 0.3× 9 0.2× 47 1.0× 89 2.3× 55 503
Tsvetelina Batsalova Bulgaria 14 152 0.9× 26 0.2× 21 0.4× 21 0.4× 40 1.1× 49 451
Renata Spagolla Napoleão Tavares Brazil 11 42 0.2× 58 0.4× 22 0.4× 47 1.0× 48 1.3× 13 301
Amnah Alzahmi United Arab Emirates 8 194 1.1× 82 0.6× 18 0.3× 8 0.2× 23 0.6× 13 386
Antonio Alcaide Spain 4 109 0.6× 92 0.6× 8 0.2× 51 1.1× 14 0.4× 9 315
Ahmed Ghannam Syria 10 141 0.8× 48 0.3× 7 0.1× 135 2.8× 19 0.5× 11 433

Countries citing papers authored by Liangqian Jiang

Since Specialization
Citations

This map shows the geographic impact of Liangqian Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liangqian Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liangqian Jiang more than expected).

Fields of papers citing papers by Liangqian Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liangqian Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liangqian Jiang. The network helps show where Liangqian Jiang may publish in the future.

Co-authorship network of co-authors of Liangqian Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Liangqian Jiang. A scholar is included among the top collaborators of Liangqian Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liangqian Jiang. Liangqian Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Qi, Yijun, et al.. (2025). Two Nonsense GLI3 Variants Are Identified in Two Chinese Families With Polydactyly. Molecular Genetics & Genomic Medicine. 13(3). e70088–e70088.
2.
Jiang, Liangqian, et al.. (2025). DTX3L E3 ligase: Molecular functions, regulatory mechanisms, and potential as a novel cancer biomarker and therapeutic target. International Journal of Biological Macromolecules. 321(Pt 1). 146194–146194.
3.
Li, Ya, et al.. (2024). Tspan protein family: focusing on the occurrence, progression, and treatment of cancer. Cell Death Discovery. 10(1). 187–187. 11 indexed citations
4.
Li, Lin, et al.. (2022). Clinical exome sequencing identifies novel compound heterozygous mutations of the POMT2 gene in patients with limb‐girdle muscular dystrophy. International Journal of Developmental Neuroscience. 83(1). 23–30.
5.
Liu, Guoxiang, Xiaohui Xu, Liangqian Jiang, et al.. (2020). Targeted Antitumor Mechanism of C-PC/CMC-CD55sp Nanospheres in HeLa Cervical Cancer Cells. Frontiers in Pharmacology. 11. 906–906. 11 indexed citations
6.
Liu, Guoxiang, Yujuan Wang, Huihui Liu, et al.. (2018). A study on screening and antitumor effect of CD55-specific ligand peptide in cervical cancer cells. Drug Design Development and Therapy. Volume 12. 3899–3912. 10 indexed citations
7.
Jiang, Liangqian, Yujuan Wang, Guoxiang Liu, et al.. (2018). C-Phycocyanin exerts anti-cancer effects via the MAPK signaling pathway in MDA-MB-231 cells. Cancer Cell International. 18(1). 12–12. 99 indexed citations
8.
Jiang, Liangqian, Yujuan Wang, Feng Zhu, et al.. (2018). Molecular Mechanism of Anti-Cancer Activity of the Nano-Drug C-PC/CMC-CD59sp NPs in Cervical Cancer. Journal of Cancer. 10(1). 92–104. 25 indexed citations
9.
Jiang, Liangqian, Yujuan Wang, Guoxiang Liu, et al.. (2017). Phycocyanin: A Potential Drug for Cancer Treatment. Journal of Cancer. 8(17). 3416–3429. 166 indexed citations
10.
Wang, Yujuan, et al.. (2017). The Targeted Antitumor Effects of C- PC/CMC-CD59sp Nanoparticles on HeLa Cells in Vitro and in Vivo. Journal of Cancer. 8(15). 3001–3013. 10 indexed citations
11.
Ji, Qinghong, Huili Hu, Fan Yang, et al.. (2014). CRL4B interacts and coordinates with SIN3A/HDAC complex to repress CDKN1A in driving cell cycle progression. Journal of Cell Science. 127(Pt 21). 4679–91. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xuegan Yang Breakdown of academic impact, for papers by Xuejun Fu Breakdown of academic impact, for papers by Sivanesan Dhandayuthapani Breakdown of academic impact, for papers by Quan Luo Breakdown of academic impact, for papers by Yong Bae Seo Breakdown of academic impact, for papers by Tsvetelina Batsalova Breakdown of academic impact, for papers by Renata Spagolla Napoleão Tavares Breakdown of academic impact, for papers by Amnah Alzahmi Breakdown of academic impact, for papers by Antonio Alcaide Breakdown of academic impact, for papers by Ahmed Ghannam
Rankless by CCL
2026